Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Iversen

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Danish Medical Journal|May 9, 2013
Patients undergoing radical prostatectomy have a better survival than the background populationMartin Andreas Røder, Klaus Brasso, Kasper Drimer Berg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 4, 2019
Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuliAnna Sophie Thue Hvilsom, Thea P Lillethorup, Peter Iversen, et al.
Scandinavian Journal of Urology and Nephrology|February 11, 2012
First Danish single-institution experience with radical prostatectomy: impact of surgical margins on biochemical outcomeMarie-Louise Vrang, Martin Andreas Røder, Ben Vainer, et al.
The Journal of Urology|January 10, 2004
Chemotherapeutic prevention studies of prostate cancerBob Djavan, Alexandre Zlotta, Claude Schulman, et al.
BJU International|June 7, 2014
Repeated biopsies in patients with prostate cancer on active surveillance: clinical implications of interobserver variation in histopathological assessmentFrederik B Thomsen, Niels Marcussen, Kasper D Berg, et al.
The Prostate|April 2, 2011
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancerCharlotte E Almasi, Klaus Brasso, Peter Iversen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2017
Diagnostic characteristics of lethal prostate cancerJohn Thomas Helgstrand, Martin Andreas Røder, Nina Klemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survivalJulia S Johansen, Klaus Brasso, Peter Iversen, et al.
Acta Oncologica (Stockholm, Sweden)|December 3, 2016
Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factorsSigne Benzon Larsen, Klaus Brasso, Jane Christensen, et al.
The Prostate|June 9, 2015
The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapyKasper D Berg, Martin A Røder, Frederik B Thomsen, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Danish Medical Journal|May 9, 2013
Patients undergoing radical prostatectomy have a better survival than the background populationMartin Andreas Røder, Klaus Brasso, Kasper Drimer Berg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 4, 2019
Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuliAnna Sophie Thue Hvilsom, Thea P Lillethorup, Peter Iversen, et al.
Scandinavian Journal of Urology and Nephrology|February 11, 2012
First Danish single-institution experience with radical prostatectomy: impact of surgical margins on biochemical outcomeMarie-Louise Vrang, Martin Andreas Røder, Ben Vainer, et al.
The Journal of Urology|January 10, 2004
Chemotherapeutic prevention studies of prostate cancerBob Djavan, Alexandre Zlotta, Claude Schulman, et al.
BJU International|June 7, 2014
Repeated biopsies in patients with prostate cancer on active surveillance: clinical implications of interobserver variation in histopathological assessmentFrederik B Thomsen, Niels Marcussen, Kasper D Berg, et al.
The Prostate|April 2, 2011
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancerCharlotte E Almasi, Klaus Brasso, Peter Iversen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2017
Diagnostic characteristics of lethal prostate cancerJohn Thomas Helgstrand, Martin Andreas Røder, Nina Klemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survivalJulia S Johansen, Klaus Brasso, Peter Iversen, et al.
Acta Oncologica (Stockholm, Sweden)|December 3, 2016
Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factorsSigne Benzon Larsen, Klaus Brasso, Jane Christensen, et al.
The Prostate|June 9, 2015
The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapyKasper D Berg, Martin A Røder, Frederik B Thomsen, et al.
Pageof 16